Voices
Humaid Al-Shamsi: New Partnership Between Nexomic and Genomics England to Validate DeepOmic
Humaid Al-Shamsi/ LinkedIn

Humaid Al-Shamsi: New Partnership Between Nexomic and Genomics England to Validate DeepOmic

Humaid Al-Shamsi, the Chairman of Nexomic and the CEO of Burjeel Cancer Institute (BCI) Comprehensive Cancer Center, shared on LinkedIn:

“We are excited to announce a new partnership between Nexomic and Genomics England.

This partnership will enable us to validate DeepOmic, our tumour-agnostic foundation model, using large-scale multi-omics data from cancer patients.”

Read more

Humaid Al-Shamsi

Other articles about Nexomic on OncoDaily.

BCI Burjeel Cancer Institute Comprehensive Cancer Center cancer DeepOmic Genomics England Humaid Al-Shamsi Nexomic OncoDaily Oncology